Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00093080
Status:
COMPLETED
Last Update Posted:
2015-02-13
First Post:
2004-09-30
Brief Title:
Study of AP23573MK-8669 Ridaforolimus A Mammalian Target of Rapamycin mTOR Inhibitor in Participants With Advanced Sarcoma MK-8669-018 AM1COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-10
Start Date Type:
None
Primary Completion Date:
2008-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-11
Completion Date Type:
ACTUAL
First Submit Date:
2004-09-30
First Submit QC Date:
October 1 2004
Study First Post Date:
2004-10-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-02-12
Last Update Post Date:
2015-02-13
Last Update Post Date Type:
ESTIMATED